Crux Biomedical Vena Cava Filter Study - United States

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

January 31, 2012

Conditions
Pulmonary Embolism
Interventions
DEVICE

Inferior Vena Cava Filter

Inplant of filter in inferior vena cava.

Trial Locations (17)

12208

Albany Medical Center, Albany

13210

Upstate Medical Center, Syracuse

15213

University of Pittsburgh Medical Center, Pittsburgh

17033

Hershey Medical Center, Hershey

21401

Anne Arundel Medical Center, Annapolis

27599

University of North Carolina Medical Center, Chapel Hill

30312

Atlanta Medical Center, Atlanta

30901

University Hospital, Augusta

32610

University of Florida Medical Center, Gainesville

43606

Jobst Vascular Institute, Toledo

60637

University of Chicago Medical Center, Chicago

61637

St. Francis Hospital, Peoria

92868

St. Joseph's Hospital, Orange

University of California at Irvine Medical Center, Orange

95817

Univeristy of California at Davis Medical Center, Sacramento

Unknown

Christiana Care, Newark

University of Virginia Medical Center, Charlottesville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Crux Biomedical

INDUSTRY